Taiwan is pushing money and policy into its biomedical industry, good news for drug and medical device makers looking to sell abroad.

• Taiwan's biomedical industry brought in NT$830 billion last year, with several homegrown drugs and devices winning international approval.
• The National Development Fund approved a plan in August to put NT$10 billion into the sector over ten years, helping companies turn research into sellable products.
• Supply chains are shifting worldwide and new tariffs are reshaping trade, so the government is treating this as the moment to make the industry tougher.
• Taiwan plans to combine its existing strengths in AI, chips, and big data with healthcare to push into smart and precision medicine.

Outlook: Expect more state-backed funding and tie-ups between Taiwan's tech and medical sectors as the island tries to turn local wins into global market share.